123 related articles for article (PubMed ID: 1953780)
1. Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues.
Weitzberg E; Ahlborg G; Lundberg JM
Biochem Biophys Res Commun; 1991 Nov; 180(3):1298-303. PubMed ID: 1953780
[TBL] [Abstract][Full Text] [Related]
2. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
[TBL] [Abstract][Full Text] [Related]
3. ET-3 is extracted by and induces potent vasoconstriction in human splanchnic and renal vasculatures.
Weitzberg E; Hemsén A; Lundberg JM; Ahlborg G
J Appl Physiol (1985); 1995 Oct; 79(4):1255-9. PubMed ID: 8567570
[TBL] [Abstract][Full Text] [Related]
4. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man.
Ahlborg G; Weitzberg E; Sollevi A; Lundberg JM
Acta Physiol Scand; 1992 Jun; 145(2):139-49. PubMed ID: 1636443
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans.
Ahlborg G; Weitzberg E; Lundberg JM
J Appl Physiol (1985); 1995 Jul; 79(1):141-5. PubMed ID: 7559211
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 infusion reduces splanchnic glucose production in humans.
Ahlborg G; Weitzberg E; Lundberg JM
J Appl Physiol (1985); 1994 Jul; 77(1):121-6. PubMed ID: 7961223
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase inhibition potentiates the renal vascular response to endothelin-1 in humans.
Ahlborg G; Lundberg JM
J Appl Physiol (1985); 1998 Nov; 85(5):1661-6. PubMed ID: 9804567
[TBL] [Abstract][Full Text] [Related]
8. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats.
Gardiner SM; Compton AM; Bennett T
Br J Pharmacol; 1990 Jan; 99(1):107-12. PubMed ID: 2139584
[TBL] [Abstract][Full Text] [Related]
9. Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation.
Wagner OF; Vierhapper H; Gasic S; Nowotny P; Waldhäusl W
Eur J Clin Invest; 1992 Apr; 22(4):277-82. PubMed ID: 1499643
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal fragment of big endothelin-1 does not potentiate the vasoactive effects of endothelin-1.
Ottosson-Seeberger A; Hemsén A; Lundberg JM; Ahlborg G
Clin Physiol; 1998 Jan; 18(1):61-8. PubMed ID: 9545622
[TBL] [Abstract][Full Text] [Related]
11. Sequential changes in the splanchnic circulation during continuous endotoxin infusion in sedated sheep: evidence for a selective increase of hepatic artery blood flow and loss of the hepatic arterial buffer response.
Schiffer ER; Mentha G; Schwieger IM; Morel DR
Acta Physiol Scand; 1993 Mar; 147(3):251-61. PubMed ID: 8475754
[TBL] [Abstract][Full Text] [Related]
12. Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans.
Ahlborg G; Weitzberg E; Lundberg JM
Clin Physiol; 1992 Mar; 12(2):145-53. PubMed ID: 1582134
[TBL] [Abstract][Full Text] [Related]
13. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men.
Böhm F; Pernow J; Lindström J; Ahlborg G
Clin Sci (Lond); 2003 Feb; 104(2):143-51. PubMed ID: 12546636
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
15. Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig.
Hemsén A; Pernow J; Lundberg JM
Acta Physiol Scand; 1991 Mar; 141(3):325-34. PubMed ID: 1858505
[TBL] [Abstract][Full Text] [Related]
16. Renal and hemodynamic effects of endothelin in anesthetized dogs.
Tsuchiya K; Naruse M; Sanaka T; Naruse K; Zeng ZP; Nitta K; Demura H; Shizume K; Sugino N
Am J Hypertens; 1990 Oct; 3(10):792-5. PubMed ID: 2222945
[TBL] [Abstract][Full Text] [Related]
17. Systemic and regional effects of endothelin in rabbits: effects of endothelin antibody.
Miyamori I; Itoh Y; Matsubara T; Koshida H; Takeda R
Clin Exp Pharmacol Physiol; 1990 Oct; 17(10):691-6. PubMed ID: 2272127
[TBL] [Abstract][Full Text] [Related]
18. Potent vasoconstrictor effects and clearance of endothelin in the human forearm.
Pernow J; Hemsén A; Lundberg JM; Nowak J; Kaijser L
Acta Physiol Scand; 1991 Mar; 141(3):319-24. PubMed ID: 1858504
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of rat endothelin on regional blood flow in the cat.
Minkes RK; Kadowitz PJ
Eur J Pharmacol; 1989 Jun; 165(1):161-4. PubMed ID: 2670586
[TBL] [Abstract][Full Text] [Related]
20. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.
Rabelink TJ; Kaasjager KA; Boer P; Stroes EG; Braam B; Koomans HA
Kidney Int; 1994 Aug; 46(2):376-81. PubMed ID: 7967349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]